drug

GSK4527226

1 story · latest Oct 15, 2026

Follow GSK4527226. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by GlaxoSmithKline

Timeline

Recursion prices $200M offering, reports Sanofi milestone and TUPELO, DAHLIA data

Oct 15Quarterly updateAlector, Inc.REC-1245Updated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.